Joseph R Triggs1, Dustin A Carlson2, Claire Beveridge3, Wenjun Kou2, Peter J Kahrilas2, John E Pandolfino2. 1. Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: joseph.triggs@pennmedicine.upenn.edu. 2. Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 3. Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND & AIMS: The etiologies of esophagogastric junction outflow obstruction (EGJOO) vary, as do their therapeutic implications. We aimed to identify patients with EGJOO most likely to benefit from achalasia-type treatment, based on findings from functional luminal imaging probe (FLIP) panometry. METHODS: We performed a retrospective study of 34 patients who received a diagnosis of EGJOO from January 2015 through July 2017. Our analysis included patients who had been evaluated with timed barium esophagram, FLIP, or upper endoscopy. RESULTS: Among the 34 patients with idiopathic EGJOO, 7 (21%) had a normal esophagogastric junction distensibility index (EGJ-DI), based on FLIP panometry, and all had repetitive antegrade contractions. None of the patients had radiographic evidence of EGJOO (RAD-EGJOO), defined as liquid barium retention and/or barium tablet impaction. On the other hand, all 18 patients with RAD-EGJOO had an EGJ-DI less than 2 mm2/mm Hg. Nine of the 18 patients with RAD-EGJOO and EGJ-DI less than 2 mm2/mm Hg underwent achalasia-type treatment, and 77.8% of these (7 of 9) had improvements in Eckardt score. Of the 6 patients with a normal EGJ-DI (>3 mm2/mm Hg) who were treated conservatively and followed up, 100% had improvements in subsequent Eckardt scores. CONCLUSIONS: We found that FLIP is useful in identifying patients with EGJOO who are most likely to benefit from achalasia-type therapy. Patients with a low EGJ-DI responded well to achalasia-type treatment, whereas patients with normal results from FLIP panometry had good outcomes from conservative management. FLIP panometry might help select management strategies for this difficult population of patients.
BACKGROUND & AIMS: The etiologies of esophagogastric junction outflow obstruction (EGJOO) vary, as do their therapeutic implications. We aimed to identify patients with EGJOO most likely to benefit from achalasia-type treatment, based on findings from functional luminal imaging probe (FLIP) panometry. METHODS: We performed a retrospective study of 34 patients who received a diagnosis of EGJOO from January 2015 through July 2017. Our analysis included patients who had been evaluated with timed barium esophagram, FLIP, or upper endoscopy. RESULTS: Among the 34 patients with idiopathic EGJOO, 7 (21%) had a normal esophagogastric junction distensibility index (EGJ-DI), based on FLIP panometry, and all had repetitive antegrade contractions. None of the patients had radiographic evidence of EGJOO (RAD-EGJOO), defined as liquid barium retention and/or barium tablet impaction. On the other hand, all 18 patients with RAD-EGJOO had an EGJ-DI less than 2 mm2/mm Hg. Nine of the 18 patients with RAD-EGJOO and EGJ-DI less than 2 mm2/mm Hg underwent achalasia-type treatment, and 77.8% of these (7 of 9) had improvements in Eckardt score. Of the 6 patients with a normal EGJ-DI (>3 mm2/mm Hg) who were treated conservatively and followed up, 100% had improvements in subsequent Eckardt scores. CONCLUSIONS: We found that FLIP is useful in identifying patients with EGJOO who are most likely to benefit from achalasia-type therapy. Patients with a low EGJ-DI responded well to achalasia-type treatment, whereas patients with normal results from FLIP panometry had good outcomes from conservative management. FLIP panometry might help select management strategies for this difficult population of patients.
Authors: Anand S Jain; Dustin A Carlson; Joseph Triggs; Michael Tye; Wenjun Kou; Ryan Campagna; Eric Hungness; Donald Kim; Peter J Kahrilas; John E Pandolfino Journal: Am J Gastroenterol Date: 2019-09 Impact factor: 10.864
Authors: Dustin A Carlson; C Prakash Gyawali; Peter J Kahrilas; Joseph R Triggs; Sophia Falmagne; Jacqueline Prescott; Emily Dorian; Wenjun Kou; Zhiyue Lin; John E Pandolfino Journal: Gastrointest Endosc Date: 2019-07-04 Impact factor: 9.427
Authors: P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino Journal: Neurogastroenterol Motil Date: 2014-12-03 Impact factor: 3.598
Authors: Dustin A Carlson; Peter J Kahrilas; Zhiyue Lin; Ikuo Hirano; Nirmala Gonsalves; Zoe Listernick; Katherine Ritter; Michael Tye; Fraukje A Ponds; Ian Wong; John E Pandolfino Journal: Am J Gastroenterol Date: 2016-10-11 Impact factor: 10.864
Authors: An Moonen; Vito Annese; Ann Belmans; Albert J Bredenoord; Stanislas Bruley des Varannes; Mario Costantini; Bertrand Dousset; J I Elizalde; Uberto Fumagalli; Marianne Gaudric; Antonio Merla; Andre J Smout; Jan Tack; Giovanni Zaninotto; Olivier R Busch; Guy E Boeckxstaens Journal: Gut Date: 2015-11-27 Impact factor: 23.059
Authors: Erwin Rieder; Lee L Swanström; Silvana Perretta; Johannes Lenglinger; Martin Riegler; Christy M Dunst Journal: Surg Endosc Date: 2012-09-06 Impact factor: 4.584
Authors: Katharine P Rooney; Alexandra J Baumann; Erica Donnan; Wenjun Kou; Joseph R Triggs; Jacqueline Prescott; Alex Decorrevont; Emily Dorian; Peter J Kahrilas; John E Pandolfino; Dustin A Carlson Journal: Clin Gastroenterol Hepatol Date: 2020-04-11 Impact factor: 11.382
Authors: Dustin A Carlson; Alexandra J Baumann; Jacqueline E Prescott; Erica N Donnan; Rena Yadlapati; Abraham Khan; C Prakash Gyawali; Wenjun Kou; Peter J Kahrilas; John E Pandolfino Journal: Neurogastroenterol Motil Date: 2021-06-13 Impact factor: 3.598
Authors: Rena Yadlapati; Peter J Kahrilas; Mark R Fox; Albert J Bredenoord; C Prakash Gyawali; Sabine Roman; Arash Babaei; Ravinder K Mittal; Nathalie Rommel; Edoardo Savarino; Daniel Sifrim; André Smout; Michael F Vaezi; Frank Zerbib; Junichi Akiyama; Shobna Bhatia; Serhat Bor; Dustin A Carlson; Joan W Chen; Daniel Cisternas; Charles Cock; Enrique Coss-Adame; Nicola de Bortoli; Claudia Defilippi; Ronnie Fass; Uday C Ghoshal; Sutep Gonlachanvit; Albis Hani; Geoffrey S Hebbard; Kee Wook Jung; Philip Katz; David A Katzka; Abraham Khan; Geoffrey Paul Kohn; Adriana Lazarescu; Johannes Lengliner; Sumeet K Mittal; Taher Omari; Moo In Park; Roberto Penagini; Daniel Pohl; Joel E Richter; Jordi Serra; Rami Sweis; Jan Tack; Roger P Tatum; Radu Tutuian; Marcelo F Vela; Reuben K Wong; Justin C Wu; Yinglian Xiao; John E Pandolfino Journal: Neurogastroenterol Motil Date: 2021-01 Impact factor: 3.598
Authors: Dustin A Carlson; Alexandra J Baumann; Jacqueline E Prescott; Jacob M Schauer; Amanda Krause; Erica N Donnan; Wenjun Kou; Peter J Kahrilas; John E Pandolfino Journal: Am J Gastroenterol Date: 2021-10-01 Impact factor: 12.045
Authors: Dustin A Carlson; Jacqueline E Prescott; Alexandra J Baumann; Jacob M Schauer; Amanda Krause; Erica N Donnan; Wenjun Kou; Peter J Kahrilas; John E Pandolfino Journal: Clin Gastroenterol Hepatol Date: 2021-06-30 Impact factor: 13.576
Authors: Dustin A Carlson; Alexandra J Baumann; Erica N Donnan; Amanda Krause; Wenjun Kou; John E Pandolfino Journal: Neurogastroenterol Motil Date: 2021-03-11 Impact factor: 3.960
Authors: Edoardo Savarino; Massimiliano di Pietro; Albert J Bredenoord; Dustin A Carlson; John O Clarke; Abraham Khan; Marcelo F Vela; Rena Yadlapati; Daniel Pohl; John E Pandolfino; Sabine Roman; C Prakash Gyawali Journal: Am J Gastroenterol Date: 2020-11 Impact factor: 12.045
Authors: Amanda J Krause; Hui Su; Joseph R Triggs; Claire Beveridge; Alexandra J Baumann; Erica Donnan; John E Pandolfino; Dustin A Carlson Journal: Neurogastroenterol Motil Date: 2020-10-11 Impact factor: 3.598